Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Memory impairment, Pain of skin, Parosmia, Pyrexia, Rash
Clinical narrative: skin hurt all over and it "hurt to the touch and not to the touch."; spotty taste and smell; periodic shortness of breath; There are times I can't get thoughts verbalized without pauses to have to purposefully think about the words/message I want to conve; headache; extreme fatigue; a spiking fever (from 99-101.5 F); Chills; injection site is also itchy, slightly red,; red dots scattered on both arms that look like measles; injection site is also itchy, slightly red, hot, and there are red dots scattered on both arms that look; she developed a large red oval rash on her shoulder.; shakes; skin hypersensitivity; injection site was hot; experiencing memory issues; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (shakes), SENSITIVE SKIN (skin hypersensitivity), PAIN OF SKIN (skin hurt all over and it "hurt to the touch and not to the touch."), VACCINATION SITE WARMTH (injection site was hot) and RASH MORBILLIFORM (red dots scattered on both arms that look like measles) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032821A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 from 09-Mar-2021 to 20-Mar-2021 and Bronchitis (Bronchitis j/ Sinus Infection) from 22-Mar-2021 to 10-Apr-2021. Concurrent medical conditions included Drug allergy (Sulfa) and Drug allergy (Clendamycin). Concomitant products included MONTELUKAST SODIUM (SINGULAIR) and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy, AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE (DYMISTA) for Allergy and Sinusitis, CEFDINIR from 30-Jan-2021 to an unknown date for Sinus infection, VITAMIN D3 from 01-Jan-2019 to an unknown date, VITAMIN C [ASCORBIC ACID] from 01-Jan-2019 to an unknown date and PROBIOTICS NOS from 01-Jan-2019 to an unknown date for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced MEMORY IMPAIRMENT (experiencing memory issues). On 07-Apr-2021, the patient experienced VACCINATION SITE WARMTH (injection site was hot). On 08-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TREMOR (shakes), SENSITIVE SKIN (skin hypersensitivity), RASH MORBILLIFORM (red dots scattered on both arms that look like measles), VACCINATION SITE PRURITUS (injection site is also itchy, slightly red, hot, and there are red dots scattered on both arms that look), RASH (she developed a large red oval rash on her shoulder.), CHILLS (Chills) and VACCINATION SITE ERYTHEMA (injection site is also itchy, slightly red,). On 09-Apr-2021, the patient experienced PYREXIA (a spiking fever (from 99-101.5 F)). On an unknown date, the patient experienced PAIN OF SKIN (skin hurt all over and it "hurt to the touch and not to the touch."), PAROSMIA (spotty taste and smell), DYSPNOEA (periodic shortness of breath), THINKING ABNORMAL (There are times I can't get thoughts verbalized without pauses to have to purposefully think about the words/message I want to conve), HEADACHE (headache) and FATIGUE (extreme fatigue). The patient was treated with GUAIFENESIN (MUCINEX) at a dose of 1 dosage form and CORTISONE at an unspecified dose and frequency. On 11-Apr-2021, TREMOR (shakes), PYREXIA (a spiking fever (from 99-101.5 F)) and CHILLS (Chills) had resolved. On 12-Apr-2021, VACCINATION SITE WARMTH (injection site was hot), RASH MORBILLIFORM (red dots scattered on both arms that look like measles), VACCINATION SITE PRURITUS (injection site is also itchy, slightly red, hot, and there are red dots scattered on both arms that look) and VACCINATION SITE ERYTHEMA (injection site is also itchy, slightly red,) had resolved. On 15-Apr-2021, RASH (she developed a large red oval rash on her shoulder.) had resolved. On 16-Apr-2021, SENSITIVE SKIN (skin hypersensitivity) had resolved. At the time of the report, PAIN OF SKIN (skin hurt all over and it "hurt to the touch and not to the touch."), PAROSMIA (spotty taste and smell), DYSPNOEA (periodic shortness of breath), MEMORY IMPAIRMENT (experiencing memory issues), THINKING ABNORMAL (There are times I can't get thoughts verbalized without pauses to have to purposefully think about the words/message I want to conve), HEADACHE (headache) and FATIGUE (extreme fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Body temperature: 99-101.5 f (abnormal) spiking fever (from 99-101.5 F).         Treatment medication included allergy medications, and a nasal spray   This case was linked to US-MODERNATX, INC.-MOD-2021-074950 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 17-Apr-2021: Additional information  on 17 -APR-2021, patient Race and Ethnicity has been updated ,concomitant medications were updated.; Sender's Comments: Based on the current available information and the temporal association between the product use and the start date of the events a causal relationship cannot be excluded. US-MODERNATX, INC.-MOD-2021-074950: